favipiravir and Monkey-Diseases

favipiravir has been researched along with Monkey-Diseases* in 1 studies

Trials

1 trial(s) available for favipiravir and Monkey-Diseases

Article	Year
Use of Favipiravir to Treat Lassa Virus Infection in Macaques. Emerging infectious diseases, 2018, Volume: 24, Issue:9 Lassa virus, the cause of Lassa fever in humans, is endemic to West Africa. Treatment of Lassa fever is primarily supportive, although ribavirin has shown limited efficacy if administered early during infection. We tested favipiravir in Lassa virus-viremic macaques and found that 300 mg/kg daily for 2 weeks successfully treated infection. Topics: Amides; Animals; Antiviral Agents; Female; Injections, Subcutaneous; Lassa Fever; Lassa virus; Macaca; Monkey Diseases; Pyrazines; Random Allocation; Treatment Outcome	2018

Article

Year

Use of Favipiravir to Treat Lassa Virus Infection in Macaques.

Emerging infectious diseases, 2018, Volume: 24, Issue:9

Lassa virus, the cause of Lassa fever in humans, is endemic to West Africa. Treatment of Lassa fever is primarily supportive, although ribavirin has shown limited efficacy if administered early during infection. We tested favipiravir in Lassa virus-viremic macaques and found that 300 mg/kg daily for 2 weeks successfully treated infection.

Topics: Amides; Animals; Antiviral Agents; Female; Injections, Subcutaneous; Lassa Fever; Lassa virus; Macaca; Monkey Diseases; Pyrazines; Random Allocation; Treatment Outcome

2018